Business Wire

Cellino and Matricelf Announce Global Collaboration to Scale Personalized Spinal Cord Injury Treatments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino and Matricelf (TASE: MTLF) announced today a collaboration to accelerate the global biomanufacturing of personalized spinal cord injury treatments using ...
Yahoo Finance

Matricelf (TASE: MTLF) Enters Strategic Collaboration with Sheba Medical Center to Advance First in Human Clinical Program in Spinal Cord Injury

TEL AVIV, Israel, March 24, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing autologous engineered neural tissue therapies, today announced a strategic ...
Morningstar

Matricelf to Attend The Digital Spine & Pain Neuroscience Summit 2026 in Phoenix, Arizona

PHOENIX and NESS ZIONA, Israel, Feb. 26, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company advancing personalized curative treatments for spinal cord injury, announced ...
Nasdaq

Matricelf technology in treating paralysis due to chronic spinal cord injury in mice with the world's first 3D engineered neural tissue implant

TEL AVIV, Israel, Feb. 7, 2022 /PRNewswire/ -- Matricelf (TASE:MTLF) announced today that scientists from Sagol Center for Regenerative Biotechnology at Tel Aviv University have engineered 3D spinal ...
Yahoo Finance

Matricelf Ltd. (TASE: MTLF) Signs MOU to Establish Subsidiary for Commercialization of Parkinson's Disease Therapy

NESS ZIONA, Israel, March 3, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a biotechnology company developing autologous engineered tissue therapies, today announced that it has signed a ...
Barron's

Matricelf Ltd.

Matricelf Ltd. is a biotechnology company, which engages in research and development of a platform for autologous matrix and cell implants in the field of regenerative medicine and tissue engineering.
Morningstar

Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board

Mr. Mayron holds a BSc in Industrial Engineering and Management from Ben Gurion University and an MBA from Tel Aviv University. He has served as CEO and owner of RonMed Ltd. since 2015 and brings ...
Seeking Alpha

Matricelf Ltd. (TASE: MTLF) Reports 2025 Milestones and Outlines 2026 Strategic Roadmap Toward First-in-Human Spinal Cord Implantation

NESS ZIONA, Israel, Feb. 26, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a biotechnology company developing personalized regenerative therapies for spinal cord injury, today issued a shareholder ...